Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

Cited by (1,001)

Items 201–300 of 1,001

1. Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
   Renaud Sabatier, Pascal Finetti, Arnaud Guillé, José Adélaı̈de, Max Chaffanet, Patrice Viens, Daniel Birnbaum, François Bertucci · 2014 · Molecular Cancer
2. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα
   Adrian Britschgi, Stephan Duss, Sungeun Kim, Joana Pinto Couto, Heike Brinkhaus, Shany Koren, Duvini De Silva, Kirsten D. Mertz, Daniela Kaup, Zsuzsanna Varga et al. · 2017 · Nature
3. Quantification of regenerative potential in primary human mammary epithelial cells
   Jelena R. Linnemann, Haruko Miura, Lisa K. Meixner, Martin Irmler, Uwe J. Kloos, Benjamin Hirschi, Harald S. Bartsch, Steffen Sass, Johannes Beckers, Fabian Joachim Theis et al. · 2015 · Development
4. Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity
   Geoffrey M. Wahl, Benjamin T. Spike · 2017 · npj Breast Cancer
5. Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity
   Christopher Dravis, Chi‐Yeh Chung, Nikki K. Lytle, Jaslem Herrera-Valdez, Gidsela Luna, Christy L. Trejo, Tannishtha Reya, Geoffrey M. Wahl · 2018 · Cancer Cell
6. The Cancer Stem-Cell Hypothesis: Its Emerging Role in Lung Cancer Biology and Its Relevance for Future Therapy
   John D. O’Flaherty, Martin P. Barr, Dean Anthony Fennell, Derek J. Richard, John Vincent Reynolds, John J. O’Leary, Kenneth John O'Byrne · 2012 · Journal of Thoracic Oncology
7. Wnt/β-catenin Signaling in Normal and Cancer Stem Cells
   Kenneth C. Valkenburg, Carrie R. Graveel, Cassandra R. Diegel, Zhendong A. Zhong, Bart O. Williams · 2011 · Cancers
8. Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling
   Justin A. Colacino, Ebrahim Azizi, Michael D. Brooks, Ramdane A Harouaka, Shamileh Fouladdel, Sean McDermott, Michael Lee, David R. Hill, Julie M. Madden, Julie L. Boerner et al. · 2018 · Stem Cell Reports
9. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures
   Peter Kabos, Jessica Finlay-Schultz, Chunling Li, Enos C. Kline, Christina A. Finlayson, Joshua A. Wisell, Christopher A Manuel, Susan M. Edgerton, Joshua Chuck Harrell, ANTHONY D. ELIAS et al. · 2012 · Breast Cancer Research and Treatment
10. Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence
    Maja Sedic, Adam Skibinski, Nelson E. Brown, Mercedes Gallardo, Peter Mulligan, Paula Martínez, Patricia J. Keller, Eugene Glover, Andrea L. Richardson, Janet M. Cowan et al. · 2015 · Nature Communications
11. The RasGAP Gene, RASAL2, Is a Tumor and Metastasis Suppressor
    Sara Koenig McLaughlin, Sarah Naomi Olsen, Benjamin T. Dake, Thomas De Raedt, Elgene Lim, Roderick Terry Bronson, Rameen Beroukhim, Kornélia Polyák, Myles A Brown, Charlotte Kuperwasser et al. · 2013 · Cancer Cell
12. SLUG: Critical regulator of epithelial cell identity in breast development and cancer
    Sarah M. Phillips, Charlotte Kuperwasser · 2014 · Cell Adhesion & Migration
13. Molecular Homology and Difference between Spontaneous Canine Mammary Cancer and Human Breast Cancer
    Deli Liu, Huan Xiong, Angela E. Ellis, Nicole C. Northrup, Carlos O. Rodriguez, Ruth M O'Regan, Stephen Dalton, Shaying Zhao · 2014 · Cancer Research
14. Identification of quiescent and spatially restricted mammary stem cells that are hormone responsive
    Nai Yang Fu, Anne C. Rios, Bhupinder Pal, Charity W. Law, Paul R. Jamieson, Ruijie Liu, François Vaillant, Felicity C. Jackling, Kevin He Liu, Gordon K. Smyth et al. · 2017 · Nature Cell Biology
15. Overview of recent advances in metastatic triple negative breast cancer
    David O'Reilly, Maha AlSendi, Catherine Margaret Kelly · 2021 · World Journal of Clinical Oncology
16. Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity
    Johanna Holm, Louise Eriksson, Alexander Ploner, Mikael Eriksson, Mattias Rantalainen, Jingmei Li, Per N Hall, Kamila Czene · 2017 · Cancer Research
17. A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis
    Trupti Paranjape, Helen Heneghan, Robert M. Lindner, Florence K. Keane, Aaron E. Hoffman, Antoinette Hollestelle, Jemima J. Dorairaj, Kimberly Geyda, Cory Pelletier, Sunitha V. Nallur et al. · 2011 · The Lancet Oncology
18. The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
    Marion A. Salvador, Julien Wicinski, Olivier Cabaud, Yves Toiron, Pascal Finetti, Emmanuelle Josselin, Hélène Lelièvre, Laurence Kraus‐Berthier, Stéphane Depil, François Bertucci et al. · 2013 · Clinical Cancer Research
19. Sox10 Regulates Stem/Progenitor and Mesenchymal Cell States in Mammary Epithelial Cells
    Christopher Dravis, Benjamin T. Spike, Joshua Chuck Harrell, Claire Johns, Christy L. Trejo, E. Michelle Southard‐Smith, Charles M. Perou, Geoffrey M. Wahl · 2015 · Cell Reports
20. Form and Function: how Estrogen and Progesterone Regulate the Mammary Epithelial Hierarchy
    Lisa M. Arendt, Charlotte Kuperwasser · 2015 · Journal of Mammary Gland Biology and Neoplasia
21. Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer
    Sproul, Duncan, Nestor, Colm, Culley, Jayne, Dickson, Jacqueline H., Dixon, J. Michael, Harrison, David J., Meehan, Richard R., Sims, Andrew H., Ramsahoye, Bernard H. · 2011 · Proceedings of the National Academy of Sciences
22. Breast cancer stem cells: treatment resistance and therapeutic opportunities
    Fares Al‐Ejeh, Chanel Elisha Smart, Brian J. Morrison, Georgia Chenevix‐Trench, José Alejandro López, Sunil R. Lakhani, Michael Paul Brown, Kum Kum Khanna · 2011 · Carcinogenesis
23. Immune Landscape of Breast Cancers
    Divya Nagarajan, Stéphanie McArdle · 2018 · Biomedicines
24. MAP3K4/CBP-Regulated H2B Acetylation Controls Epithelial-Mesenchymal Transition in Trophoblast Stem Cells
    Amy N. Abell, Nicole Vincent Jordan, Weichun Huang, Aleix Prat, Alicia A. Midland, Nancy Lassignal Johnson, Deborah A. Granger, Piotr A. Mieczkowski, Charles M. Perou, Shawn M. Gomez et al. · 2011 · Cell stem cell
25. Links between cancer stem cells and epithelial– mesenchymal transition
    Yaling Tang, Shasha Wang, Jian Dong Jiang, Xin‐hua Liang · 2015 · OncoTargets and Therapy
26. Mammary stem cells and progenitors: targeting the roots of breast cancer for prevention
    Pirashaanthy Tharmapalan, Mathepan Jeya Mahendralingam, Hal K. Berman, Rama Khokha · 2019 · The EMBO Journal
27. ANTXR1, a Stem Cell-Enriched Functional Biomarker, Connects Collagen Signaling to Cancer Stem-like Cells and Metastasis in Breast Cancer
    Daohong Chen, Poornima Bhat‐Nakshatri, Chirayu Pankaj Goswami, Sunil Badve, Harikrishna Nakshatri · 2013 · Cancer Research
28. Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction
    Pierre‐Emmanuel Colombo, Fernanda Milanezi, Britta Weigelt, Jorge Sergio Reis-Filho · 2011 · Breast Cancer Research
29. Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4
    Diana M. Cittelly, Jessica Finlay-Schultz, Erin N. Howe, Nicole S. Spoelstra, Sunshine Daddario Axlund, P Hendricks, Britta M. Jacobsen, Carol A. Sartorius, Jennifer K. Richer · 2012 · Oncogene
30. Lunatic Fringe Deficiency Cooperates with the Met/Caveolin Gene Amplicon to Induce Basal-like Breast Cancer
    Keli Xu, Jerry Usary, Philaretos C. Kousis, Aleix Prat, Dong‐Yu Wang, Jessica R. Adams, Wei Wang, Amanda J. Loch, Tao Deng, Wei Zhao et al. · 2012 · Cancer Cell
31. Tumor size and survival in breast cancer—a reappraisal
    William David Foulkes, Jorge Sergio Reis-Filho, Steven Alexander Narod · 2010 · Nature Reviews Clinical Oncology
32. Luminal Expression of PIK3CA Mutant H1047R in the Mammary Gland Induces Heterogeneous Tumors
    Dominique S. Meyer, Heike Brinkhaus, Urs Müller, Matthias Müller, Robert D. Cardiff, Mohamed Bentires‐Alj · 2011 · Cancer Research
33. BRCA1 and Breast Cancer: Molecular Mechanisms and Therapeutic Strategies
    Xiaoyu Fu, Wei Tan, Qibin Song, Huadong Pei, Juanjuan Li · 2022 · Frontiers in Cell and Developmental Biology
34. Breast cancer stem cells and epithelial mesenchymal plasticity – Implications for chemoresistance
    Cletus Pinto, Edwin Widodo, Mark C. Waltham, Erik W. Thompson · 2013 · Cancer Letters
35. From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer
    Benjamin Tiede, Yibin Kang · 2011 · Cell Research
36. Insights into cancer metastasis from a clinicopathologic perspective: Epithelial‐Mesenchymal Transition is not a necessary step
    Michael Herman Chui · 2012 · International Journal of Cancer
37. Accumulation of Multipotent Progenitors with a Basal Differentiation Bias during Aging of Human Mammary Epithelia
    James C. Garbe, Francois Pepin, Fanny A. Pelissier, Klara Sputova, Agla J. Fridriksdottir, Diana E. Guo, René Villadsen, Morag Park, Ole W. Petersen, Alexander D. Borowsky et al. · 2012 · Cancer Research
38. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
    kConFab Investigators, Valentina Silvestri, EMBRACE, Daniel Barrowdale, Anna Marie Mulligan, Susan L. Neuhausen, Stephen B. Fox, Beth Y. Karlan, Gillian Mitchell, Paul Andrew James et al. · 2016 · Breast Cancer Research
39. Mammary Development and Breast Cancer: A Wnt Perspective
    Qing Cissy Yu, Esther M. Verheyen, Yi Arial Zeng · 2016 · Cancers
40. A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial Cancers
    Bryan A. Smith, Nikolas G. Balanis, Avinash Nanjundiah, Katherine M. Sheu, Brandon L. Tsai, Qingfu Zhang, Jung Wook Park, Michael J. Thompson, Jiaoti Huang, Owen N. Witte et al. · 2018 · Cell Reports
41. A Single Cell Atlas of the Healthy Breast Tissues Reveal Clinically Relevant Clusters of Breast Epithelial Cells
    Poornima Bhat‐Nakshatri, Hongyu Gao, Sheng Liu, Patrick C. McGuire, Xiaoling Xuei, Jun Wan, Yunlong Liu, Sandra K. Althouse, Austyn B. Colter, George Earl Sandusky et al. · 2020 · Cell Reports Medicine
42. Estrogen and Progesterone in Normal Mammary Gland Development and in Cancer
    Julia Stingl · 2010 · Hormones and Cancer
43. Stem Cells in the Human Breast
    OLE WILLIAM PETERSEN, Kornélia Polyák · 2010 · Cold Spring Harbor Perspectives in Biology
44. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity
    Jiyoung Kim, René Villadsen, Thérese Sørlie, Louise Fogh, Signe Z. Grønlund, Agla J. Fridriksdottir, Irene Kuhn, Fritz E Rank, Vera Timmermans Wielenga, Hiroko Kato Solvang et al. · 2012 · Proceedings of the National Academy of Sciences
45. Gata-3 Negatively Regulates the Tumor-Initiating Capacity of Mammary Luminal Progenitor Cells and Targets the Putative Tumor Suppressor Caspase-14
    Marie-Liesse Asselin-Labat, Kate D. Sutherland, François Vaillant, David E. Gyorki, Di Wu, Sheridan L Holroyd, Kelsey A. Breslin, Teresa A. Ward, Wei Shi, Mary L. Bath et al. · 2011 · Molecular and Cellular Biology
46. Analysis of Normal Human Mammary Epigenomes Reveals Cell-Specific Active Enhancer States and Associated Transcription Factor Networks
    Davide Pellacani, Misha Bilenky, Nagarajan Kannan, Alireza Heravi‐Moussavi, David J. H. F. Knapp, Sitanshu Gakkhar, Michelle Moksa, Annaïck Carles, Richard A. Moore, Andrew J. J. Mungall et al. · 2016 · Cell Reports
47. Transcriptional changes in the mammary gland during lactation revealed by single cell sequencing of cells from human milk
    Alecia‐Jane Twigger, Lisa K. Engelbrecht, Karsten Bach, Isabel Schultz-Pernice, Sara Pensa, Jack Stenning, Stefania Petricca, Christina Scheel, Walid T. Khaled · 2022 · Nature Communications
48. Effects of estrogen on the proportion of stem cells in the breast
    Bruno M. Simões, Marco Piva, Oihana Iriondo, Valentine Comaills, Jose A. López-Ruiz, Iñaki Zabalza, Jon A. Mieza, Olga Acinas, María dM Vivanco · 2010 · Breast Cancer Research and Treatment
49. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer
    Joseph L. Regan, Howard D. Kendrick, F-A Magnay, Vida Vafaizadeh, Bernd Groner, Matthew John Smalley · 2011 · Oncogene
50. NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation
    Kai Miao, J. Lei, Monica V. Valecha, Aiping Zhang, Jun Xu, Lijian Wang, Xueying Lyu, Si Chen, Zheng-Qiang Miao, Xin Zhang et al. · 2020 · Nature Communications
51. CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer
    Ólafur Andri Stefánsson, Jon Gunnlaugur Jonasson, Kristrún Ólafsdóttir, Hólmfríður Hilmarsdóttir, Guðríður H. Ólafsdóttir, Manel Esteller, Óskar Þór Jóhannsson, Jorunn Erla Eyfjord · 2011 · Epigenetics
52. BRCA1 is a negative modulator of the PRC2 complex
    Lan Wang, Xianzhuo Zeng, Shuai Chen, Liya Ding, Jian Zhong, Jonathan C. Zhao, Liguo Wang, Aaron L. Sarver, Antonius A. Koller, Jizu Zhi et al. · 2013 · The EMBO Journal
53. ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis
    Ying Liu, Donglai Lv, Jiang‐Jie Duan, Senlin Xu, Jingfang Zhang, Xiaojun Yang, Xia Zhang, You‐Hong Cui, Xiu‐Wu Bian, Shi‐Cang Yu · 2014 · BMC Cancer
54. A single-cell atlas enables mapping of homeostatic cellular shifts in the adult human breast
    Austin D. Reed, Sara Pensa, Adi Steif, Jack Stenning, Daniel J. Kunz, Linsey J. Porter, Kui Hua, Peng He, Alecia‐Jane Twigger, Abigail J. Q. Siu et al. · 2024 · Nature Genetics
55. Health disparities in breast cancer: biology meets socioeconomic status
    Barbara Karen Dunn, Tanya Agurs‐Collins, Doris Browne, Ronald A. Lubet, Karen A. Johnson · 2010 · Breast Cancer Research and Treatment
56. Targeting Unique Metabolic Properties of Breast Tumor Initiating Cells
    Weiguo Feng, Andrew J. Gentles, Ramesh V. Nair, Min Huang, Yuan Lin, Cleo Y. Lee, Shang Cai, Ferenc A. Scheeren, Angera H. Kuo, Maximilian Diehn · 2014 · Stem Cells
57. Cell-State Transitions Regulated by SLUG Are Critical for Tissue Regeneration and Tumor Initiation
    Sarah M. Phillips, Aleix Prat, Maja Sedic, Theresa A. Proia, Ania Wronski, Sohini Mazumdar, Adam Skibinski, Stephanie Harkey Shirley, Charles M. Perou, Grace Gill et al. · 2014 · Stem Cell Reports
58. Combined deletion of Pten and p53 in mammary epithelium accelerates triple‐negative breast cancer with dependency on eEF2K
    Jeff C. Liu, Véronique Voisin, Sharon Wang, Dong‐Yu Wang, Robert A. Jones, Alessandro Datti, David Uehling, Rima Al‐awar, Sean E. Egan, Gary D. Bader et al. · 2014 · EMBO Molecular Medicine
59. Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers
    Peter Kabos, James M. Haughian, Xinshuo Wang, Wendy W. Dye, Christina A. Finlayson, ANTHONY D. ELIAS, Kathryn B. Horwitz, Carol A. Sartorius · 2010 · Breast Cancer Research and Treatment
60. TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer
    Alejandra Bruna, Wendy Greenwood, John P. C. Le Quesne, Andrew Erich Teschendorff, Diego Miranda‐Saavedra, Oscar M. Rueda, José Luís Sandoval, Ana Tufegdžić Vidaković, Amel Saadi, Paul D.P. Pharoah et al. · 2012 · Nature Communications
61. Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage
    A. C. SAU, Rosanna Lau, Miguel A. Cabrita, Emma Nolan, Peter Anthony Crooks, Jane E. Visvader, M.A. Christine Pratt · 2016 · Cell stem cell
62. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease
    Susana García‐Recio, Aatish Thennavan, Michael P. East, Joel S. Parker, Juan Miguel Cejalvo, Joseph P. Garay, Daniel P. Hollern, Xiaping He, Kevin Raynard Mott, Patricia Galván et al. · 2020 · Journal of Clinical Investigation
63. Epigenetic Regulation of Cell Type–Specific Expression Patterns in the Human Mammary Epithelium
    Maruyama, Reo, Choudhury, Sibgat, Kowalczyk, Adam, Bessarabova, Marina, Beresford-Smith, Bryan, Conway, Thomas, Kaspi, Antony, Wu, Zhenhua, Nikolskaya, Tatiana, Merino, Vanessa F. et al. · 2011 · PLoS Genetics
64. The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy
    Mun Ngah Hui, Aurélie Cazet, Radhika Nair, D. Neil Watkins, Sandra A O'Toole, Alexander Swarbrick · 2013 · Breast Cancer Research
65. RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells
    Maaike P.A. van Bragt, Xin Hu, Ying Xie, Zhe Li · 2014 · eLife
66. Lineage-Biased Stem Cells Maintain Estrogen-Receptor-Positive and -Negative Mouse Mammary Luminal Lineages
    Chunhui Wang, John R. Christin, Maja H. Oktay, Wenjun Guo · 2017 · Cell Reports
67. Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution
    Roxane M. Pommier, Amélien Sanlaville, Laurie Tonon, Janice Kielbassa, Emilie Thomas, Anthony Ferrari, Anne-Sophie Sertier, Frédéric Hollande, Pierre Martinez, Agnès Tissier et al. · 2020 · Nature Communications
68. Basal Cell Signaling by p63 Controls Luminal Progenitor Function and Lactation via NRG1
    Nicole Forster, Srinivas Vinod Saladi, Maaike P.A. van Bragt, Mary E. Sfondouris, Frank E. Jones, Zhe Li, Leif William Ellisen · 2014 · Developmental Cell
69. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
    Helen Schneck, Berthold Gierke, Frauke Uppenkamp, Bianca Behrens, Dieter Niederacher, Nikolas Hendrik Stoecklein, Markus F. Templin, Michael Pawlak, Tanja Natascha Fehm, Hans J. Neubauer et al. · 2015 · PLoS ONE
70. Epigenetic Modifications in Breast Cancer and Their Role in Personalized Medicine
    Ólafur Andri Stefánsson, Manel Esteller · 2013 · American Journal Of Pathology
71. DNA barcoding reveals diverse growth kinetics of human breast tumour subclones in serially passaged xenografts
    Long V. Nguyen, Claire L. Cox, Peter D. Eirew, David J. H. F. Knapp, Davide Pellacani, Nagarajan Kannan, Annaïck Carles, Michelle Moksa, Sneha Balani, Sohrab P. Shah et al. · 2014 · Nature Communications
72. Single-Cell Chromatin Analysis of Mammary Gland Development Reveals Cell-State Transcriptional Regulators and Lineage Relationships
    Chi‐Yeh Chung, Zhibo Ma, Christopher Dravis, Sebastian Preißl, Olivier Poirion, Gidsela Luna, Xiaomeng Hou, Rajshekhar R. Giraddi, Bing Ren, Geoffrey M. Wahl · 2019 · Cell Reports
73. Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic Characteristics
    Sonam Bhatia, Melissa Kramer, Suzanne Russo, Payal Naik, Gayatri Arun, Kyle Brophy, Peter Andrews, Cheng Fan, Charles M. Perou, Jonathan B. Preall et al. · 2022 · Cancer Research
74. Breast Cancer Stem Cells: Current Advances and Clinical Implications
    Ming Luo, Shawn G. Clouthier, Yadwinder S. Deol, Suling Liu, Sunitha Nagrath, Ebrahim Azizi, Max S. Wicha · 2015 · Methods in molecular biology
75. Invasive Breast Carcinoma
    Ayşegül A. Şahin, H. Zhang · 2014 · Elsevier eBooks
76. Revisiting the concept of cancer stem cells in prostate cancer
    Zhu A. Wang, Michael M. Shen · 2010 · Oncogene
77. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a–LCOR axis
    Toni Celià-Terrassa, Daniel Dan Liu, Abrar Choudhury, Xiang Hang, Yong Wei, Jose Zamalloa, Raymundo Alfaro‐Aco, Rumela Chakrabarti, Yi‐Zhou Jiang, Bong Ihn Koh et al. · 2017 · Nature Cell Biology
78. The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
    Alessandro Allegra, Andrea Alonci, Giuseppa Penna, Vanessa Innao, Demetrio Gabriele Gerace, Francesco Rotondo, Caterina Musolino · 2014 · Cancer Investigation
79. BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II–DNA complexes
    Hiroyuki Sasanuma, Masataka Tsuda, Suguru Morimoto, Liton Kumar Saha, Md Maminur Rahman, Yusuke Kiyooka, Haruna Fujiike, Andrew D. Cherniack, Junji Itou, Elsa Callén et al. · 2018 · Proceedings of the National Academy of Sciences
80. KIF14 Promotes AKT Phosphorylation and Contributes to Chemoresistance in Triple-Negative Breast Cancer
    Stina Mui Singel, Crystal Cornelius, Elma Zaganjor, Kimberly G. Batten, Venetia Rumnong Sarode, Dennis L. Buckley, Yan Shen Peng, George B. John, Hsiao Ching Li, Navid Sadeghi et al. · 2014 · Neoplasia
81. Glutathione-dependent and -independent oxidative stress-control mechanisms distinguish normal human mammary epithelial cell subsets
    Nagarajan Kannan, Long V. Nguyen, Maisam Makarem, Yifei Dong, Kingsley Shih, Peter D. Eirew, Afshin Raouf, Joanne T. Emerman, Connie J. Eaves · 2014 · Proceedings of the National Academy of Sciences
82. Genetic Fate Mapping of Transient Cell Fate Reveals N-Cadherin Activity and Function in Tumor Metastasis
    Yan Li, Zan Lv, Shaohua Zhang, Zhuo Wang, Lingjuan He, Muxue Tang, Wenjuan Pu, Huan Zhao, Zhenqian Zhang, Qihui Shi et al. · 2020 · Developmental Cell
83. Targeted therapy for triple‐negative breast cancer: Where are we?
    Michael Joe Duffy, Patricia M. McGowan, John Paul Crown · 2012 · International Journal of Cancer
84. GABA(A) Receptor Pi (GABRP) Stimulates Basal-like Breast Cancer Cell Migration through Activation of Extracellular-regulated Kinase 1/2 (ERK1/2)
    Gina M. Sizemore, Steven T. Sizemore, Darcie D. Seachrist, Ruth A. Keri · 2014 · Journal of Biological Chemistry
85. Epithelial‐to‐mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity
    Deli Hong, Andrew J. Fritz, Sayyed Kaleem Zaidi, André J. van Wijnen, Jeffrey A. Nickerson, Anthony N. Imbalzano, Jane B. Lian, Janet Lee Stein, Gary S. Stein · 2018 · Journal of Cellular Physiology
86. Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch
    James M. Haughian, Mauricio P. Pinto, Joshua Chuck Harrell, Brian Bliesner, Kristiina M. Joensuu, Wendy W. Dye, Carol A. Sartorius, Aik Choon Tan, Päivi Heikkilä, Charles M. Perou et al. · 2011 · Proceedings of the National Academy of Sciences
87. R-spondin1 is a novel hormone mediator for mammary stem cell self-renewal
    Cheguo Cai, Qing Cissy Yu, Weimin Jiang, Wei Liu, Wenqian Song, Hua Yu, Lei Zhang, Ying Yang, Yi Arial Zeng · 2014 · Genes & Development
88. Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer
    Hua Wang, Dongxi Xiang, Ben Liu, Aina He, Helena J. Randle, Kelvin Xi Zhang, Anushka Dongre, Norman Sachs, Allison P. Clark, Luwei Tao et al. · 2019 · Cell
89. Steroid Hormones, Steroid Receptors, and Breast Cancer Stem Cells
    Jessica Finlay-Schultz, Carol A. Sartorius · 2015 · Journal of Mammary Gland Biology and Neoplasia
90. Generation of tumor-initiating cells by exogenous delivery of OCT4transcription factor
    Adriana S. Beltrán, Ashley G. Rivenbark, Bryan T Richardson, Xinni Yuan, Haili Quian, John P Hunt, Eric I. Zimmerman, Lee M. Graves, Pilar Blancafort · 2011 · Breast Cancer Research
91. MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion
    Jessica Bockhorn, Kathy Yee, Ya-Fang Chang, Aleix Prat, Dezheng Huo, Chika Nwachukwu, Rachel Dalton, Simo Huang, Kaitlin E. Swanson, Charles M. Perou et al. · 2012 · Breast Cancer Research and Treatment
92. Hyaluronan Mediated Motility Receptor (HMMR) Encodes an Evolutionarily Conserved Homeostasis, Mitosis, and Meiosis Regulator Rather than a Hyaluronan Receptor
    Zhengcheng He, Lin Mei, Marisa Connell, Christopher A. Maxwell · 2020 · Cells
93. ErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancer
    Kunihiko Hinohara, Seiichiro Kobayashi, Hajime Kanauchi, Seiichiro Shimizu, Kotoe Nishioka, Ei-ichi Tsuji, Kei-ichiro Tada, Kazuo Umezawa, Masaki Mori, Toshihisa Ogawa et al. · 2012 · Proceedings of the National Academy of Sciences
94. Dysregulation of the BRCA1/long non-coding RNA NEAT1 signaling axis contributes to breast tumorigenesis
    Pang‐Kuo Lo, Yongshu Zhang, Benjamin Wolfson, Ramkishore Gernapudi, Yuan Yao, Nadire Duru, Qun Yong Zhou · 2016 · Oncotarget
95. Poly (ADP-Ribose) Polymerase as a Novel Therapeutic Target in Cancer
    Christina M. Annunziata, Joyce O’Shaughnessy · 2010 · Clinical Cancer Research
96. Role of microRNAs in the Regulation of Breast Cancer Stem Cells
    Suling Liu, Shawn G. Clouthier, Max S. Wicha · 2012 · Journal of Mammary Gland Biology and Neoplasia
97. Mapping cancer origins
    R. Gilbertson · 2011 · Cell
98. Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma
    Toshima Z. Parris, Anna Danielsson, Szilárd Nemes, Anikó Kovács, Ulla Delle, Ghita Fallenius, Elin Möllerström, Per Karlsson, Khalil Helou · 2010 · Clinical Cancer Research
99. Estrogen receptor signaling is reprogrammed during breast tumorigenesis
    David Chi, Hari Singhal, Lewyn Li, Tengfei Xiao, Weihan Liu, Matthew J Pun, Rinath M. Jeselsohn, Housheng He, Elgene Lim, Raga Vadhi et al. · 2019 · Proceedings of the National Academy of Sciences
100. Breast Cancer Stem Cells
     Judy S. Crabtree, Lucio Miele · 2018 · Biomedicines